Psychiatry and Neurology, Neurology with Special Qualifications in Child Neurology · Oakland, CA
NPI
1770577652
Since 2005
Specialty
Psychiatry and Neurology, Neurology with Special Qualifications in Child Neurology
Code 2084N0402X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
3120 Webster St
Oakland, CA, 94609
Phone (510) 834-1813
Medicare paid, 2024
$61K
498 services
Medicare patients, 2024
165
Average age 75
Drug cost, 2024
$1.1M
2,547 prescriptions
Company payments, 2025
$85K
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Allen D Bott was code 99214 (office e&m - established), 349 times for 135 patients. In total Allen D Bott billed 498 services in 10 codes, and Medicare paid $61K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 349 | 135 | $106.78 | $37K |
| 99215 Office E&M - Established | Office | 50 | 43 | $153.60 | $7,680 |
| 95886 Electrical Nerve Conductivity | Office | 39 | 23 | $93.46 | $3,645 |
| 99205 Office E&M - New | Office | 30 | 30 | $190.78 | $5,723 |
By year: 2022 $62K for 512 services; 2023 $58K for 505 services; 2024 $61K for 498 services.
Medicare prescription drug claims, 2024
In 2024, the drug Allen D Bott prescribed most often to Medicare patients was Venlafaxine Hcl Er (Venlafaxine Hcl), with 203 prescriptions and refills. In total Allen D Bott wrote 2,547 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Venlafaxine Hcl Er Venlafaxine Hcl | 203 | 331 | 25 | $7,570 |
| Duloxetine Hcl Generic | 156 | 279 | 28 | $3,047 |
| Bupropion Xl Bupropion Hcl | 147 | 353 | 42 | $5,096 |
| Trintellix Vortioxetine Hydrobromide | 121 | 219 | 26 | $104K |
| Trazodone Hcl Generic | 105 | 213 | 22 | $1,307 |
| Lamotrigine Generic | 91 | 177 | 18 | $1,187 |
| Escitalopram Oxalate Generic | 88 | 188 | 20 | $1,299 |
| Quetiapine Fumarate Generic | 87 | 151 | 20 | $3,101 |
| Clonazepam Generic | 83 | 95 | 15 | $623 |
| Aripiprazole Generic | 61 | 123 | 19 | $5,425 |
| Alprazolam Generic | 58 | 64 | 11 | $593 |
| Gabapentin Generic | 58 | 94 | 17 | $1,385 |
| Mirtazapine Generic | 56 | 100 | 12 | $665 |
| Rexulti Brexpiprazole | 54 | 68 | 11 | $95K |
| Ingrezza Valbenazine Tosylate | 51 | 51 | Under 11 | $407K |
Brand drugs: - claims; generic drugs: 2,040 claims; opioid claims: 34.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Allen D Bott $85K ($85K in general payments such as food, travel and fees) from 8 companies. The largest payer was ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) with $60K.
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 78 | $60K |
| Axsome Therapeutics, Inc. AXSM | 30 | $24K |
| Neurocrine BioSciences, Inc. NBIX | 9 | $263 |
| Teva Pharmaceuticals USA, Inc. TEVA | 3 | $203 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $63.19 |
| Lundbeck LLC | 2 | $52.65 |
| ACADIA Pharmaceuticals Inc ACAD | 1 | $26.75 |
| Abbvie Inc. ABBV | 1 | $19.79 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.